Back to Search Start Over

The diagnostic value of fetal fibronectin testing in clinical practice.

Authors :
Cornelissen, Lisa G. H.
Oostrum, Noortje H. M.
Woude, Daisy A. A.
Rolf, Christel
Porath, Martina M.
Oei, S. Guid
Laar, Judith O. E. H.
Source :
Journal of Obstetrics & Gynaecology Research. Mar2020, Vol. 46 Issue 3, p405-412. 8p. 1 Diagram, 4 Charts, 2 Graphs.
Publication Year :
2020

Abstract

Aim: To evaluate the clinical management to withhold treatment for preterm labor in symptomatic women with an intermediate cervical length and negative fetal fibronectin (fFN) testing. Methods: A retrospective cohort study was performed in a tertiary care teaching hospital in the Netherlands. Pregnant women with a gestational age between 23+5 to 34+0 weeks, with the presence of regular uterine contractions accompanied by a cervical length between 15 and 30 mm and intact membranes, who underwent fFN testing were included to obtain the diagnostic value of fFN testing for preterm delivery within 7 days. Results: Fetal fibronectin testing has an extremely high negative predictive value (100%) and sensitivity (100%) for delivery within 7 days, in singleton and multiple pregnancies. However, specificity (64%) and positive predictive value (10%) of fFN testing in singleton pregnancies are low. Blood present on the fFN sample does not affect the reliability of the fFN test; the negative predictive value remains 100%. Conclusion: Women with symptoms of early preterm labor, intact membranes, a cervical length between 15 and 30 mm and negative fFN testing do not deliver within 7 days. Administration of corticosteroids and tocolytics can safely be withhold. Furthermore, blood on the fFN sample does not change the reliability of the fFN test. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
13418076
Volume :
46
Issue :
3
Database :
Academic Search Index
Journal :
Journal of Obstetrics & Gynaecology Research
Publication Type :
Academic Journal
Accession number :
141999451
Full Text :
https://doi.org/10.1111/jog.14201